Pliant Therapeutics Inc (PLRX) USD0.0001

Sell:$1.26Buy:$1.27Price increased$0.02 (1.60%)

NASDAQ:Price increased0.21%
Market closed |
Prices delayed by at least 15 minutes
Sell:$1.26
Buy:$1.27
Change:Price increased$0.02 (1.60%)
Market closed |
Prices delayed by at least 15 minutes
Sell:$1.26
Buy:$1.27
Change:Price increased$0.02 (1.60%)
Market closed |
Prices delayed by at least 15 minutes

Key metrics

Open$1.25
Previous close$1.25
Market cap$76.78m
P/E ratio-
Volume61,010
Dividend yield0.00%
EMS-

Pliant Therapeutics, Inc. is a late-stage biotechnology company, which is focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. The Company’s lead product candidate, ...

  • LocationUnited States
  • SectorHealthcare
  • IndustryBiotechnology & Drugs
  • CurrencyUSD
  • Shares in issue61.92m

Take a closer look at this company’s financial statements and dividend information.

Costs and Charges

Find out how much you might pay in costs and charges if you choose this investment.

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete and accepts no responsibility for how it may be used. TradingView Lightweight Charts™ Copyright (c) 2026 TradingView, Inc. https://www.tradingview.com/.